Rhogam, also known as Rh immunoglobulin, is a specially developed blood product that can prevent an Rh-negative mother's antibodies from attacking the fetus's Rh-positive cells. Rh-negative women will receive RhIg around the 28th week of pregnancy or at the time of an amniocentesis.